Edition:
United States

People: Merck & Co Inc (MRK.N)

MRK.N on New York Stock Exchange

63.32USD
10:50am EDT
Change (% chg)

$0.04 (+0.06%)
Prev Close
$63.28
Open
$63.16
Day's High
$63.53
Day's Low
$63.01
Volume
581,291
Avg. Vol
3,260,858
52-wk High
$66.80
52-wk Low
$52.46

Rosenblatt, Michael 

Dr. Michael Rosenblatt, M.D., is Executive Vice President, Chief Medical Officer of Merck & Co., Inc. He is responsible for the Company’s primary voice to the global medical community on critical issues such as patient safety and oversight for the Company’s Global Center for Scientific Affairs. Prior to December 2009, Dr. Rosenblatt was the Dean of Tufts University School of Medicine since 2003.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --